Why Perrigo’s latest earnings are drawing fresh attention
Perrigo (PRGO) is back in focus after third quarter results showed lower sales and a swing to a net loss, combined with guidance that points to declining net sales growth for 2026.
The health and wellness supplier also affirmed its regular dividend, keeping a quarterly payout of US$0.29 per share in place, even as management prepares for a year of expected revenue pressure.
Perrigo’s share price has moved sharply higher over the past quarter, with a 90 day share price return of 28.99% and a year to date gain of 19.15%. However, the 5 year total shareholder return is still down 51.22%, which signals recovering momentum after a difficult longer stretch.
Scan how traders are reassessing Perrigo after these earnings, and compare it with hand picked opportunities in the 32 high quality undervalued stocks universe.
Perrigo now trades at a near 49% discount to one fair value estimate and still sits below the average analyst target after a sharp rebound. Is that a genuine margin of safety, or is the market pricing in real earnings risk?
Most Popular Narrative: 8.1% Undervalued
Perrigo’s analyst consensus Narrative on Simply Wall St places fair value at $18, slightly above the last close of $16.55. This frames the recent rebound as still leaving some implied upside if that view proves accurate.
Increasing consumer cost-consciousness is driving stronger adoption of store-brand (private label) OTC products, with Perrigo reporting accelerated unit and volume share gains. This structural shift is expanding Perrigo's addressable market and supports enduring top-line revenue growth.
See why 13 investors see Perrigo as 8% undervalued.
Result: Fair Value of $18 (UNDERVALUED)
Still, Perrigo’s reliance on volume driven private label categories, combined with ongoing soft demand in key OTC and infant formula markets, could pressure margins and undercut that valuation narrative.
Find out about the key risks to this Perrigo narrative.
Next Steps
Mixed signals on Perrigo can feel confusing, so use that feeling as a prompt to move quickly, review the key metrics, and weigh both sides of the story with the full breakdown of 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Perrigo?
If Perrigo has sharpened your focus on valuation and quality, do not stop here. Broader watchlists often surface the opportunities that move first.
- Target resilient balance sheets by scanning companies with strong financial footing through our list of solid balance sheet and fundamentals (24 results).
- Hunt for attractively priced opportunities that combine quality fundamentals with potential mispricing using the 32 high quality undervalued stocks.
- Prioritise income and stability by reviewing companies that feature robust payouts screened via the 6 dividend fortresses.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com